答：　　Aisling Capital believes the next decade will be marked by a revolution in
healthcare driven by new therapeutics generated by biotechnology.
　　The completion of the human genome has given scientists new insights into
the causes of human disease.
　　These insights, combined with the past 20 years of developments in the
biotechnology industry, are leading to rapid expansion o...